Fulgent Genetics (FLGT) Cash from Financing Activities (2016 - 2026)
Fulgent Genetics (FLGT) posted Cash from Financing Activities of -$44.8 million for Q1 2026, down 8295.69% sequentially from -$534000.0 in Q4 2025, and down 301.3% YoY from $22.3 million in Q1 2025.
Fulgent Genetics (FLGT) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Fulgent Genetics (FLGT) has 11 years of Cash from Financing Activities data on file, last reported at -$44.8 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 301.3% year-over-year to -$44.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 266.71% YoY) and the FY2025 annual result came in at -$14.8 million, down 205.12% from the prior year.
- Cash from Financing Activities retreated to -$44.8 million in Q1 2026 per FLGT's latest filing, from -$534000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was -$327000.0 in Q4 2024, with the low at -$44.8 million in Q1 2026.
- Average Cash from Financing Activities over 5 years is -$11.1 million, with a median of -$2.8 million recorded in 2024.
- Year-over-year, Cash from Financing Activities slumped 1086.42% in 2022 and soared 98.74% in 2024.
- Fulgent Genetics' Cash from Financing Activities stood at -$29.6 million in 2022, then gained by 12.31% to -$26.0 million in 2023, then soared by 98.74% to -$327000.0 in 2024, then tumbled by 63.3% to -$534000.0 in 2025, then plunged by 8295.69% to -$44.8 million in 2026.
- Business Quant data shows FLGT's Cash from Financing Activities at -$44.8 million in Q1 2026, -$534000.0 in Q4 2025, and -$445000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Fulgent Genetics | 642.94 Mn | 360.99 Mn | 21.49 Mn | -44.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.83 Mn |
| Mar 31, 2026 | -44.83 Mn |
| Dec 31, 2025 | -534,000.00 |
| Dec 31, 2025 | -534,000.00 |
| Sep 30, 2025 | -445,000.00 |
| Sep 30, 2025 | -445,000.00 |
| Jun 30, 2025 | -2.64 Mn |
| Jun 30, 2025 | -2.64 Mn |
| Mar 31, 2025 | -11.17 Mn |
| Mar 31, 2025 | -11.17 Mn |
| Dec 31, 2024 | -327,000.00 |
| Dec 31, 2024 | -327,000.00 |
| Sep 30, 2024 | -567,000.00 |
| Sep 30, 2024 | -567,000.00 |
| Jun 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.15 Mn |
| Mar 31, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.81 Mn |
| Dec 31, 2023 | -25.95 Mn |
| Dec 31, 2023 | -25.95 Mn |